The regulation of medical innovation and pharmaceutical markets
Year of publication: |
2002
|
---|---|
Authors: | Philipson, Tomas J. |
Published in: |
The journal of law & economics. - Chicago, Ill. : Univ. of Chicago Press, ISSN 0022-2186, ZDB-ID 218304-3. - Vol. 45.2002, 2,2, p. 583-586
|
Subject: | Innovation | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Regulierung | Regulation | Arzneimittelmarkt | Pharmaceutical market | Medizin | Medical sciences | Pharmakologie | Pharmacology | Ärzte | Physicians |
-
Chapter 12. Pharmaceutical Innovation
Scherer, F.M., (2010)
-
Pharmaceutical Lemons : Innovation and Regulation in the Drug Industry
Katz, Ariel, (2013)
-
Estimating the cost of strategic entry delay in pharmaceuticals : the case of Ambien CR
Shapiro, Bradley T., (2016)
- More ...
-
Tetanus, Death and Aerobics: The Evaluation of Disease-Specific Public Health Interventions
Sala-i-Martin, Xavier X., (1995)
-
The Private Demand for Information and the Effects of Public Testing Programs: The Case of HIV
Boozer, Michael A., (1996)
-
Mortality Contingent Claims, Health Care, and Social Insurance
Philipson, Tomas J., (1996)
- More ...